Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration

NCT02843490 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG: Ranibizumab

Sponsor

Johannes Gutenberg University Mainz

Collaborators

[object Object]